Facebook Linkedin RSS Twitter Youtube
Home 2024

AbbVie

Top 10 Best Selling Drugs
A-Lists

Top 10 Best Selling Drugs

StockWatch: Insmed Shares Leap 150%, as Analysts See Next Blockbuster
Drug Discovery

StockWatch: Insmed Shares Leap 150%, as Analysts See Next Blockbuster

Skin in the Game: Oruka Takes on Blockbuster Drugs for Psoriasis, Dermatological Disorders
Drug Discovery

Skin in the Game: Oruka Takes on Blockbuster Drugs for Psoriasis, Dermatological Disorders

REGENXBIO and AbbVie Advance Wet AMD Gene Therapy to Phase III
Drug Discovery

REGENXBIO and AbbVie Advance Wet AMD Gene Therapy to Phase III

Bioconjugates Meet and Promise to Exceed Expectations
Drug Discovery

Bioconjugates Meet and Promise to Exceed Expectations

Smart Biomanufacturing: From Piecemeal to All of a Piece
Bioprocessing

Smart Biomanufacturing: From Piecemeal to All of a Piece

AbbVie to Acquire Cerevel for $8.7B, Growing Neuro Drug Pipeline
Drug Discovery

AbbVie to Acquire Cerevel for $8.7B, Growing Neuro Drug Pipeline

AbbVie to Acquire ImmunoGen for $10.1B, Expanding Cancer Franchise
Cancer

AbbVie to Acquire ImmunoGen for $10.1B, Expanding Cancer Franchise

Abivax Advances Ulcerative Colitis Candidate with U.S. IPO
Drug Discovery

Abivax Advances Ulcerative Colitis Candidate with U.S. IPO

AI in Clinical Trials Reality versus Hype
Artificial Intelligence

AI in Clinical Trials Reality versus Hype

123...9Page 1 of 9
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.